Clinical Trial Update: Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI [Phase 4]

View source ↗

Summary

A multicenter Phase 4 randomized 2x2 factorial trial comparing tirofiban vs abciximab and sirolimus-eluting stents vs bare-metal stents in acute myocardial infa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Abciximab (ReoPro) (abciximab)
• tirofiban (Aggrastat) (tirofiban)

Snippet

Sponsor: Marco Valgimigli | Conditions: Myocardial Infarction | Phase 4 | Status: UNKNOWN